To explore the role of Bcl-2 as a potential therapeutic target in breast cancer, Oakes et al generated a panel of primary breast tumor xenografts in immunocompromised mice and treated them with either ABT-737 (BH3 mimetic), docetaxel, or a combination. The gene discussed is BCL2; the disease is breast neoplasm.